Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.36 |
| ▸ | POLB | P06746 | 2/20 | 0.36 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.33 |
| ▸ | GAA | P10253 | 2/20 | 0.33 |
| ▸ | CTSS | P25774 | 1/20 | 0.31 |
| ▸ | CTSK | P43235 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.31 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.31 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.31 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL11240294 | 0.73 | — | — | |
| SCHEMBL15068246 | 0.72 | TSHR (0.47) | GAAALDH1A1SMN1; SMN2MEN1HPGD | |
| SCHEMBL841327 | 0.70 | MEN1 (0.48) | LMNAPOLBKDM4EL3MBTL1GAA | |
| SCHEMBL16857037 | 0.69 | KDM4E (0.41) | LMNAPOLBKDM4EL3MBTL1GAA | |
| SCHEMBL17630129 | 0.68 | CTSK (0.43) | LMNAL3MBTL1CTSKALDH1A1MAPK1 | |
| SCHEMBL15271725 | 0.68 | LMNA (0.39) | LMNAPOLBKDM4EL3MBTL1GAA | |
| SCHEMBL5146605 | 0.68 | LMNA (0.39) | LMNAPOLBKDM4EL3MBTL1GAA | |
| SCHEMBL31121771 | 0.68 | LMNA (0.39) | LMNAPOLBKDM4EL3MBTL1GAA | |
| SCHEMBL1515366 | 0.67 | HPGD (0.46) | LMNAPOLBKDM4EL3MBTL1GAA | |
| SCHEMBL678153 | 0.67 | LMNA (0.40) | LMNAPOLBKDM4EL3MBTL1GAA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-1995029897-A1 | METHOD OF USING (H+/K+) ATPase INHIBITORS AS ANTIVIRAL AGENTS | G.D. SEARLE & CO. (US) | 1995-11-09 | — | — | WO | disclosed |